135 related articles for article (PubMed ID: 20533501)
1. Novel monocyclam derivatives as HIV entry inhibitors: Design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 co-receptor.
Pettersson S; Pérez-Nueno VI; Mena MP; Clotet B; Esté JA; Borrell JI; Teixidó J
ChemMedChem; 2010 Aug; 5(8):1272-81. PubMed ID: 20533501
[TBL] [Abstract][Full Text] [Related]
2. Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors.
Wu CH; Wang CJ; Chang CP; Cheng YC; Song JS; Jan JJ; Chou MC; Ke YY; Ma J; Wong YC; Hsieh TC; Tien YC; Gullen EA; Lo CF; Cheng CY; Liu YW; Sadani AA; Tsai CH; Hsieh HP; Tsou LK; Shia KS
J Med Chem; 2015 Feb; 58(3):1452-65. PubMed ID: 25584630
[TBL] [Abstract][Full Text] [Related]
3. Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.
Sironi F; Malnati M; Mongelli N; Cozzi P; Guzzo C; Ghezzi S; Martínez-Romero C; García-Sastre A; Lusso P; Jabes D; Biswas P
J Transl Med; 2015 Apr; 13():107. PubMed ID: 25888743
[TBL] [Abstract][Full Text] [Related]
4. Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors.
Das D; Maeda K; Hayashi Y; Gavande N; Desai DV; Chang SB; Ghosh AK; Mitsuya H
Antimicrob Agents Chemother; 2015 Apr; 59(4):1895-904. PubMed ID: 25583709
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.
Wong RS; Bodart V; Metz M; Labrecque J; Bridger G; Fricker SP
Mol Pharmacol; 2008 Dec; 74(6):1485-95. PubMed ID: 18768385
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors.
Pettersson S; Pérez-Nueno VI; Ros-Blanco L; Puig de La Bellacasa R; Rabal MO; Batllori X; Clotet B; Clotet-Codina I; Armand-Ugón M; Esté J; Borrell JI; Teixidó J
ChemMedChem; 2008 Oct; 3(10):1549-57. PubMed ID: 18671217
[TBL] [Abstract][Full Text] [Related]
7. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
Gerlach LO; Skerlj RT; Bridger GJ; Schwartz TW
J Biol Chem; 2001 Apr; 276(17):14153-60. PubMed ID: 11154697
[TBL] [Abstract][Full Text] [Related]
8. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100.
Labrosse B; Brelot A; Heveker N; Sol N; Schols D; De Clercq E; Alizon M
J Virol; 1998 Aug; 72(8):6381-8. PubMed ID: 9658078
[TBL] [Abstract][Full Text] [Related]
9. Development of anti-HIV agents targeting dynamic supramolecular mechanism: entry and fusion inhibitors based on CXCR4/CCR5 antagonists and gp41-C34-remodeling peptides.
Tamamura H; Otaka A; Fujii N
Curr HIV Res; 2005 Oct; 3(4):289-301. PubMed ID: 16250877
[TBL] [Abstract][Full Text] [Related]
10. Importance of receptor flexibility in binding of cyclam compounds to the chemokine receptor CXCR4.
Lam AR; Bhattacharya S; Patel K; Hall SE; Mao A; Vaidehi N
J Chem Inf Model; 2011 Jan; 51(1):139-47. PubMed ID: 21158459
[TBL] [Abstract][Full Text] [Related]
11. New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses.
Rusconi S; Lo Cicero M; Viganò O; Sirianni F; Bulgheroni E; Ferramosca S; Bencini A; Bianchi A; Ruiz L; Cabrera C; Martinez-Picado J; Supuran CT; Galli M
Molecules; 2009 May; 14(5):1927-37. PubMed ID: 19471212
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
13. Baseline resistance of primary human immunodeficiency virus type 1 strains to the CXCR4 inhibitor AMD3100.
Harrison JE; Lynch JB; Sierra LJ; Blackburn LA; Ray N; Collman RG; Doms RW
J Virol; 2008 Dec; 82(23):11695-704. PubMed ID: 18799588
[TBL] [Abstract][Full Text] [Related]
14. HIV co-receptor inhibitors as novel class of anti-HIV drugs.
Schols D
Antiviral Res; 2006 Sep; 71(2-3):216-26. PubMed ID: 16753228
[TBL] [Abstract][Full Text] [Related]
15. CD4 mimics targeting the mechanism of HIV entry.
Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
[TBL] [Abstract][Full Text] [Related]
16. Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
Hatse S; Princen K; Gerlach LO; Bridger G; Henson G; De Clercq E; Schwartz TW; Schols D
Mol Pharmacol; 2001 Jul; 60(1):164-73. PubMed ID: 11408611
[TBL] [Abstract][Full Text] [Related]
17. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.
Narumi T; Ochiai C; Yoshimura K; Harada S; Tanaka T; Nomura W; Arai H; Ozaki T; Ohashi N; Matsushita S; Tamamura H
Bioorg Med Chem Lett; 2010 Oct; 20(19):5853-8. PubMed ID: 20728351
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
Rosenkilde MM; Gerlach LO; Hatse S; Skerlj RT; Schols D; Bridger GJ; Schwartz TW
J Biol Chem; 2007 Sep; 282(37):27354-27365. PubMed ID: 17599916
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands.
Sakyiamah MM; Kobayakawa T; Fujino M; Konno M; Narumi T; Tanaka T; Nomura W; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2019 Mar; 27(6):1130-1138. PubMed ID: 30772128
[TBL] [Abstract][Full Text] [Related]
20. N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.
Jiang S; Lu H; Liu S; Zhao Q; He Y; Debnath AK
Antimicrob Agents Chemother; 2004 Nov; 48(11):4349-59. PubMed ID: 15504864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
